TT-012
TT-012 has anti-tumor activity, selectively binds dynamic MITF and disrupts the dimer formation and DNA binding of the latter. TT-012 can inhibit the transcription of MITF in B16F10 melanoma cells. TT-012 inhibited the growth and metastasis of MITF melanoma cells in animal models. TT-012 is less cytotoxic to liver and immune cells.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
349.34
Molecular Formula
C19H15N3O4
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
1164471-33-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC203805L4V 200 µL
Papillary renal cell carcinoma (PRCC) (NM_005973) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 
MBS2038816-01 0.1 mL
APC-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
Ask
View Details 
MBS2038816-02 0.2 mL
APC-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
Ask
View Details MBS2038816-03 0.5 mL
APC-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
Ask
View Details MBS2038816-04 1 mL
APC-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
Ask
View Details MBS2038816-05 5 mL
APC-Linked Polyclonal Antibody to Vascular Endothelial Growth Factor D (VEGFD)
Ask
View Details